Uremic Encephalopathy

Uremic encephalopathy is a metabolic brain disorder resulting from the accumulation of uremic toxins in advanced kidney failure when the glomerular filtration rate falls below 15 mL/min. The pathogenesis is multifactorial: accumulation of guanidino compounds (methylguanidine, guanidinosuccinic acid) acts as excitotoxins on NMDA receptors, while elevated parathyroid hormone (secondary hyperparathyroidism) increases intracellular calcium in neurons, disrupting neurotransmission. Uremic toxins also impair the blood-brain barrier, alter cerebral metabolism, and disrupt the balance between excitatory and inhibitory neurotransmitters. Clinical manifestations progress from subtle cognitive dysfunction (impaired concentration, memory deficits) through personality changes, myoclonus, asterixis, and seizures, to obtundation and coma in severe cases. EEG characteristically shows generalized slowing with triphasic waves. The nurse monitors neurological status using GCS and orientation assessment, differentiates uremic encephalopathy from other causes of altered mental status (metabolic acidosis, electrolyte imbalances, medication toxicity, structural lesions), monitors BUN and creatinine trends, administers medications to manage complications (anticonvulsants for seizures, antihypertensives), coordinates urgent dialysis initiation (the definitive treatment, with neurological improvement expected within 24-48 hours), implements seizure precautions, and ensures patient safety during periods of confusion.